shLuc pRRL Citations (4)

Originally described in: Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression.
Godar S, Ince TA, Bell GW, Feldser D, Donaher JL, Bergh J, Liu A, Miu K, Watnick RS, Reinhardt F, McAllister SS, Jacks T, Weinberg RA Cell. 2008 Jul 11. 134(1):62-73. PubMed Journal

---

Articles Citing shLuc pRRL

Articles
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells. Weitzenfeld P, Meshel T, Ben-Baruch A. Oncotarget. 2016 Dec 6;7(49):81123-81143. doi: 10.18632/oncotarget.13213. PubMed
Acute Myeloid and Lymphoblastic Leukemia Cell Interactions with Endothelial Selectins: Critical Role of PSGL-1, CD44 and CD43. Spertini C, Baisse B, Bellone M, Gikic M, Smirnova T, Spertini O. Cancers (Basel). 2019 Aug 27;11(9). pii: cancers11091253. doi: 10.3390/cancers11091253. PubMed
Targeting Opsin4/Melanopsin with a Novel Small Molecule Suppresses PKC/RAF/MEK/ERK Signaling and Inhibits Lung Adenocarcinoma Progression. Wang Q, Zhang T, Chang X, Wang K, Lee MH, Ma WY, Liu K, Dong Z. Mol Cancer Res. 2020 Jul;18(7):1028-1038. doi: 10.1158/1541-7786.MCR-19-1120. Epub 2020 Apr 8. PubMed
Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML. Lambert M, Jambon S, Bouhlel MA, Depauw S, Vrevin J, Blanck S, Marot G, Figeac M, Preudhomme C, Quesnel B, Boykin DW, David-Cordonnier MH. Hemasphere. 2024 May 6;8(5):e77. doi: 10.1002/hem3.77. eCollection 2024 May. PubMed

If you have published an article using this material, please email us at to have your article added to this page.